| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2018 | ||||||||
|
ATP binding cassette subfamily F member 1 | 0.674 | 0.538 | 1.3E-09 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2012 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.833 | 1 | 1 | 2007 | 2018 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2000 | 2017 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 6 | 7 | 2008 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.500 | None | 0.934 | 1 | 2 | 2008 | 2018 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.500 | None | 1.000 | 4 | 13 | 2008 | 2018 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.500 | None | 0.978 | 4 | 2 | 2008 | 2019 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2008 | 2019 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2008 | 2012 | ||||||||
|
discoidin, CUB and LCCL domain containing 1 | 0.729 | 0.231 | 6.3E-08 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
fatty acid desaturase 1 | 0.582 | 0.769 | 0.37 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 6 | 2011 | 2011 | ||||||||
|
flap structure-specific endonuclease 1 | 0.550 | 0.731 | 4.8E-05 |
|
disease | 0.490 | None | 0.800 | 1 | 1 | 2003 | 2019 | ||||||||
|
flotillin 1 | 0.623 | 0.692 | 1.0E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
FRY microtubule binding protein | 0.666 | 0.500 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2012 | ||||||||
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1 | 0.931 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2009 | 2012 | |||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2012 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2012 | |||||||||
|
HORMA domain containing 2 | 0.716 | 0.385 | 7.1E-05 |
|
disease | 0.120 | None | 1.000 | 1 | 18 | 2011 | 2014 | ||||||||
|
HORMAD2 and MTMR3 antisense RNA 1 | 0.839 | 0.308 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2011 | 2011 |